In contrast, the generation of single loss-of-function (LOF) lesion using sgRNA targeting Atm, Tp53, Birc3, Chd2, Mga, or Samhd1 was not sufficient to drive CLL disease development (25). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.